Bergan Kdv Wealth Management, LLC Abb Vie Inc. Transaction History

Bergan Kdv Wealth Management, LLC

$999 Million
Q2 2023

A detailed history of Bergan Kdv Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 13,689 shares of ABBV stock, worth $2.42 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

13,689

Previous 13,512 1.31%

Holding current value

$2.42 Million

Previous $2.15 Million 14.35%

% of portfolio

0.18%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$132.51 - $164.9 $23,454 - $29,187	177 Added 1.31%	13,689 $1.84 Million
Q1 2023 Apr 27, 2023	BUY	$144.61 - $166.54 $20,534 - $23,648	142 Added 1.06%	13,512 $2.15 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $25,310 - $30,354	183 Added 1.39%	13,370 $2.16 Million
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $28,855 - $33,094	215 Added 1.66%	13,187 $1.77 Million
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $412 - $524	3 Added 0.02%	12,972 $1.99 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $923 - $1,146	7 Added 0.05%	12,969 $2.1 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $12,032 - $15,224	112 Added 0.87%	12,962 $1.76 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $93,206 - $105,803	876 Added 7.32%	12,850 $1.39 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $315 - $351	3 Added 0.03%	11,974 $1.35 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $818 - $900	-8 Reduced 0.07%	11,971 $1.3 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $2,897 - $3,912	36 Added 0.3%	11,979 $1.28 Million
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $257 - $302	3 Added 0.03%	11,943 $1.05 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $20,910 - $27,981	-285 Reduced 2.33%	11,940 $1.17 Million
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $66,306 - $100,528	-1,028 Reduced 7.76%	12,225 $931,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $1.3 Million - $1.62 Million	-17,971 Reduced 57.56%	13,253 $1.17 Million
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $32,056 - $38,541	-509 Reduced 1.6%	31,224 $2.36 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $404,974 - $517,652	6,164 Added 24.11%	31,733 $2.31 Million
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $262,276 - $308,686	3,400 Added 15.34%	25,569 $2.06 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $54,728 - $67,495	-703 Reduced 3.07%	22,169 $2.04 Million
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $28,362 - $31,529	319 Added 1.41%	22,872 $2.16 Million
Q2 2018 Jul 23, 2018	SELL	$89.78 - $106.23 $69,130 - $81,797	-770 Reduced 3.3%	22,553 $2.09 Million
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $23,646 - $31,664	-257 Reduced 1.09%	23,323 $2.21 Million
Q4 2017 Jan 16, 2018	SELL	$89.56 - $98.21 $192,195 - $210,758	-2,146 Reduced 8.34%	23,580 $2.28 Million
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $1.8 Million - $2.3 Million	25,726	25,726 $2.29 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.

Account

Bergan Kdv Wealth Management, LLC Abb Vie Inc. Transaction History